SCHEMBL30967564

SCHEMBL30967564

Nc1nc2c(F)ccc(OCCF)c2s1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 2/20 0.41
▸ HTR2C P28335 10/20 0.38
▸ HTR2A P28223 9/20 0.38
▸ HTR2B P41595 7/20 0.38
▸ CYBB P04839 1/20 0.36
▸ NCF1 P14598 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.34
▸ LMNA P02545 1/20 0.34
▸ PIK3CD O00329 1/20 0.33
▸ PIK3CA P42336 1/20 0.33
▸ PIK3CB P42338 1/20 0.33
▸ PI4KA P42356 1/20 0.33
▸ PIK3CG P48736 1/20 0.33
▸ PI4KB Q9UBF8 1/20 0.33
▸ DCK P27707 1/20 0.32
▸ CYP3A4 P08684 1/20 0.32
▸ TDP1 Q9NUW8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30967565 0.93 SMN1; SMN2 (0.40) SMN1; SMN2HTR2CHTR2AHTR2BCYBB
SCHEMBL30967452 0.87 MCHR1 (0.40) SMN1; SMN2CYBBNCF1KDM4EMAPK1
SCHEMBL12804043 0.80 CYP3A4 (0.50) SMN1; SMN2KDM4EMAPK1HSD17B10ALDH1A1
SCHEMBL30967646 0.71 KDM4E (0.44) SMN1; SMN2CYBBNCF1KDM4EMAPK1
SCHEMBL30967561 0.70 HSD17B10 (0.40) SMN1; SMN2KDM4EMAPK1HSD17B10ALDH1A1
SCHEMBL25323852 0.70 KDM4E (0.68) SMN1; SMN2KDM4EMAPK1HSD17B10ALDH1A1
SCHEMBL288073 0.69 SMN1; SMN2 (0.49) SMN1; SMN2MAPK1HSD17B10ALDH1A1LMNA
SCHEMBL288072 0.69 SMN1; SMN2 (0.49) SMN1; SMN2KDM4EHSD17B10ALDH1A1LMNA
SCHEMBL106132 0.69 SMN1; SMN2 (0.72) SMN1; SMN2KDM4EHSD17B10ALDH1A1LMNA
SCHEMBL30967578 0.69 SMN1; SMN2 (0.49) SMN1; SMN2KDM4EALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4615838-A1 SUBSTITUTED BI-AND TRICYCLIC HSET INHIBITORS Merck Patent GmbH (DE) 2025-09-17 — — EP disclosed
WO-2024099898-A1 SUBSTITUTED BI-AND TRICYCLIC HSET INHIBITORS MERCK PATENT GMBH (DE) 2024-05-16 — — WO disclosed
Send feedback